STAT+ Conversation: The ‘Shroom Boom’
STAT’s Angus Chen and Olivia Goldhill discuss the booming psychedelics industry, highlighting opportunities for growth and potential barriers.
STAT’s Angus Chen and Olivia Goldhill discuss the booming psychedelics industry, highlighting opportunities for growth and potential barriers.
Microsoft seeks to change the way pharma industry companies use technology to better navigate human resource and supply chain challenges.
The Chan Zuckerberg Initiative announced a significant new investment into its missions of curing, preventing, or managing all diseases.
Martin Shkreli’s one-time friend and business partner, Kevin Mulleady, was also banned from the pharmaceutical industry for seven years.
While home tests have distinct advantages, most who test positive don’t come to the attention of health officials unless they see a doctor.
The settlement with Kansas is the fifth such deal this year between a state government and Centene, a major health insurer.
In the latest edition of STAT Health Tech: Telehealth backers join forces in D.C. and Pear Therapeutics makes its market debut.
An advocacy group is trying to create a path for generic manufacturers to sell the Pfizer Covid-19 pill in the Dominican Republic.
Researchers spent years trying to replicate the results of cancer studies. Their findings paint a complicated picture of reproducibility.
The term profound autism is needed to describe people with severe autism-related disabilities likely to require lifelong 24-hour support.